Radboudumc and partners

Innovation requires collaboration

Our mission is to have a significant impact on healthcare. We aim to be a front runner in the development of sustainable, innovative, and affordable healthcare.

collaboration
opportunities

contact

news

spin-off companies

licensing opportunities

our collaborations

News

setup e-mail alert

Third Radboudumc Investment Day again well-attended

16 October 2023

On October 12, the Radboudumc Investment Day took place for the third time. Scientists, entrepreneurs and investors from the life sciences & health sector came together in the Radboudumc Experience Center to exchange knowledge, network and talk about new collaborations.

Thirona Raises €7,5 Million New Financing

14 September 2023

Nijmegen, the Netherlands (September 11th, 2023) – Thirona, a global company specialized in advanced analysis of thoracic CT images with artificial intelligence and Radboudumc spin-off, is thrilled to announce the successful completion of its new investment.

Funding for Simmunext New therapy for cancer treatment

11 August 2023

An investment from the Gelderland Early Stage Funding Fund (VFF Gelderland) will allow Radboudumc spin-off Simmunext Biotherapeutics BV to continue developing a new treatment for cancer.